BusinessOncoMed Announces Third Quarter 2017 Financial Results and Operational HighlightsBy Nasdaq OMXNov 2, 2017, 8:06 PM UTC
BusinessOncoMed Doses First Patient with GITRL-Fc in Phase 1a Clinical TrialBy Nasdaq OMXSep 13, 2017, 12:05 PM UTC
BusinessOncoMed Highlights New Data Presented at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXApr 5, 2017, 12:01 PM UTC
BusinessOncoMed Highlights New Data Presented at the American Association for Cancer Research Annual Meeting 2017By Nasdaq OMXApr 5, 2017, 12:01 PM UTC
BusinessOncoMed Presents GITRL-Fc Research at the AACR Annual Meeting 2016By Nasdaq OMXApr 19, 2016, 1:00 PM UTC
BusinessOncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016By Nasdaq OMXMar 16, 2016, 8:30 PM UTC
